Due to a lack of events, primary tumor site, size ≥ 5 cm, Folpe’s and Bleeker’s risk categories and type of systemic treatment at diagnosis (none vs. chemotherapy vs. mTOR inhibitors) could not be tested. The gene discussed is MTOR; the disease is neoplasm.